Phase 3

Ivermectin, Fluvoxamine, Fluticasone, Montelukast, Metformin

Sponsor:

Susanna Naggie, MD

Code:

NCT04885530

Conditions

Covid19

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

Ivermectin

Fluvoxamine

Fluticasone

Placebo

Montelukast

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-28. This information was provided to ClinicalTrials.gov by Susanna Naggie, MD on 2024-11-13.